{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:32:52Z","timestamp":1784835172634,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02663-z","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:10:46Z","timestamp":1774782646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring a plasma proteomic biosignature associated with cardiac involvement in Fabry disease"],"prefix":"10.1007","volume":"104","author":[{"given":"Thi Hai Yen","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Thu","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin","family":"Ducatez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdellah","family":"Tebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuoc Long","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-7270","authenticated-orcid":false,"given":"Soumeya","family":"Bekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,29]]},"reference":[{"key":"2663_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP (2010) Fabry disease. Orphanet J Rare Dis 5:30","journal-title":"Orphanet J Rare Dis"},{"key":"2663_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/GIM.0b013e3181f6e676","volume":"12","author":"A Mehta","year":"2010","unstructured":"Mehta A, West ML, Pintos-Morell G, Reisin R, Nicholls K, Figuera LE, Parini R, Carvalho LR, Kampmann C, Pastores GM et al (2010) Therapeutic goals in the treatment of Fabry disease. Genet Med 12:713\u2013720. https:\/\/doi.org\/10.1097\/GIM.0b013e3181f6e676","journal-title":"Genet Med"},{"issue":"6","key":"2663_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.31083\/j.rcm2306196","volume":"23","author":"M Pieroni","year":"2022","unstructured":"Pieroni M, Ciabatti M, Graziani F, Camporeale A, Saletti E, Lillo R, Figliozzi S, Bolognese L (2022May 27) The heart in Fabry disease: mechanisms beyond storage and forthcoming therapies. Reviews in Cardiovascular Medicine. 23(6):196. https:\/\/doi.org\/10.31083\/j.rcm2306196","journal-title":"Reviews in Cardiovascular Medicine."},{"key":"2663_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11897-024-00645-1","volume":"21","author":"D Weissman","year":"2024","unstructured":"Weissman D, Dudek J, Sequeira V, Maack C (2024) Fabry disease: cardiac implications and molecular mechanisms. Curr Heart Fail Rep 21:81\u2013100","journal-title":"Curr Heart Fail Rep"},{"key":"2663_CR5","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/ncpneuro0407","volume":"3","author":"AT M\u00f8ller","year":"2007","unstructured":"M\u00f8ller AT, Jensen TS (2007) Neurological manifestations in Fabry\u2019s disease. Nature Clinical Practice Neurology 3:95\u2013106. https:\/\/doi.org\/10.1038\/ncpneuro0407","journal-title":"Nature Clinical Practice Neurology"},{"key":"2663_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002251","volume":"10","author":"K Valtola","year":"2023","unstructured":"Valtola K, Hedman M, Kantola I, Walls S, Helisalmi S, Maria M, Raivo J, Auray-Blais C, Kuusisto J (2023) Late-onset and classic phenotypes of Fabry disease in males with the GLA-Thr410Ala mutation. Open Heart 10:e002251","journal-title":"Open Heart"},{"key":"2663_CR7","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/asn.2016090964","volume":"28","author":"M Arends","year":"2017","unstructured":"Arends M, Wanner C, Hughes D, Mehta A, Oder D, Watkinson OT, Elliott PM, Linthorst GE, Wijburg FA, Biegstraaten M et al (2017) Characterization of classical and nonclassical Fabry disease: a multicenter study. J Am Soc Nephrol 28:1631\u20131641. https:\/\/doi.org\/10.1681\/asn.2016090964","journal-title":"J Am Soc Nephrol"},{"key":"2663_CR8","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","volume":"77","author":"M Pieroni","year":"2021","unstructured":"Pieroni M, Moon JC, Arbustini E, Barriales-Villa R, Camporeale A, Vujkovac AC, Elliott PM, Hagege A, Kuusisto J, Linhart A et al (2021) Cardiac involvement in Fabry disease. J Am Coll Cardiol 77:922\u2013936. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.024","journal-title":"J Am Coll Cardiol"},{"key":"2663_CR9","volume":"43","author":"R Giugliani","year":"2025","unstructured":"Giugliani R, Politei J, Martins A, Murillo N, Rozenfeld P, Lopera M, Salgado S, Quir\u00f3s G, Louren\u00e7o CM, Vieira O (2025) Expert review in diagnostic, therapeutic and follow-up of Fabry disease in Latin America based on patient care standards. Mol Genet Metab Rep 43:101218","journal-title":"Mol Genet Metab Rep"},{"key":"2663_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15020139","volume":"15","author":"C Tognola","year":"2025","unstructured":"Tognola C, Ruzzenenti G, Maloberti A, Varrenti M, Mazzone P, Giannattasio C, Guarracini F (2025) Anderson\u2013Fabry disease: an overview of current diagnosis, arrhythmic risk stratification, and therapeutic strategies. Diagnostics 15:139","journal-title":"Diagnostics"},{"key":"2663_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101274","author":"NTH Yen","year":"2025","unstructured":"Yen NTH, Tien NTN, Thu NQ, Ducatez F, Mauhin W, Lidove O, Bekri S, Tebani A, Long NP (2025) A multi-omics-empowered framework for precision diagnosis and treatment of lysosomal diseases. J Pharm Anal. https:\/\/doi.org\/10.1016\/j.jpha.2025.101274","journal-title":"J Pharm Anal"},{"key":"2663_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ymgme.2020.10.006","volume":"132","author":"F Rossi","year":"2021","unstructured":"Rossi F, L\u2019Imperio V, Marti H-P, Svarstad E, Smith A, Bolognesi MM, Magni F, Pagni F, Pieruzzi F (2021) Proteomics for the study of new biomarkers in Fabry disease: state of the art. Mol Genet Metab 132:86\u201393. https:\/\/doi.org\/10.1016\/j.ymgme.2020.10.006","journal-title":"Mol Genet Metab"},{"key":"2663_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010226","author":"VJ \u00c1lvarez","year":"2020","unstructured":"\u00c1lvarez VJ, Bravo SB, Chantada-Vazquez MP, Col\u00f3n C, De Castro MJ, Morales M, Vitoria I, Tomatsu S, Otero-Espinar FJ, Couce ML (2020) Characterization of new proteomic biomarker candidates in mucopolysaccharidosis type IVA. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010226","journal-title":"Int J Mol Sci"},{"key":"2663_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.trsl.2023.02.006","volume":"258","author":"A Tebani","year":"2023","unstructured":"Tebani A, Barbey F, Dormond O, Ducatez F, Marret S, Nowak A, Bekri S (2023) Deep next-generation proteomics and network analysis reveal systemic and tissue-specific patterns in Fabry disease. Transl Res 258:47\u201359","journal-title":"Transl Res"},{"key":"2663_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bib\/bbx124","volume":"20","author":"F Degenhardt","year":"2017","unstructured":"Degenhardt F, Seifert S, Szymczak S (2017) Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform 20:492\u2013503","journal-title":"Brief Bioinform"},{"key":"2663_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2023.1187578","author":"F Hamidi","year":"2023","unstructured":"Hamidi F, Gilani N, Arabi Belaghi R, Yaghoobi H, Babaei E, Sarbakhsh P, Malakouti J (2023) Identifying potential circulating miRNA biomarkers for the diagnosis and prediction of ovarian cancer using machine-learning approach: application of Boruta. Front Digit Health. https:\/\/doi.org\/10.3389\/fdgth.2023.1187578","journal-title":"Front Digit Health"},{"key":"2663_CR17","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, Spigelman Aliya F, MacDonald Patrick E, Wishart David S, Li S et al (2024) MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res 52:W398\u2013W406","journal-title":"Nucleic Acids Res"},{"key":"2663_CR18","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1021\/acs.jproteome.4c01068","volume":"24","author":"NTN Tien","year":"2025","unstructured":"Tien NTN, Thu NQ, Kim DH, Park S, Long NP (2025) Easypubplot: a shiny web application for rapid omics data exploration and visualization. J Proteome Res 24:2188\u20132195","journal-title":"J Proteome Res"},{"key":"2663_CR19","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, Tang W, Wang Q, Liu B, Wang R et al (2024) Using clusterProfiler to characterize multiomics data. Nat Protoc 19:3292\u20133320. https:\/\/doi.org\/10.1038\/s41596-024-01020-z","journal-title":"Nat Protoc"},{"key":"2663_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i11","volume":"36","author":"MB Kursa","year":"2010","unstructured":"Kursa MB, Rudnicki WR (2010) Feature selection with the Boruta package. J Stat Softw 36:1\u201313","journal-title":"J Stat Softw"},{"issue":"3","key":"2663_CR21","first-page":"18","volume":"2","author":"A Liaw","year":"2002","unstructured":"Liaw A, Wiener M (2002Dec 3) Classification and regression by randomForest. R news. 2(3):18\u201322","journal-title":"R news."},{"key":"2663_CR22","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5c00540","author":"S-H Li","year":"2025","unstructured":"Li S-H, Song M, Wang P, Kou T-s, Peng X-x, Ye H, Li H (2025) XGBoost- and mass spectrometry-based feature selection for identifying metabolic biomarkers associated with HBV-related liver disease progression and hepatocellular carcinoma treatment. J Proteome Res. https:\/\/doi.org\/10.1021\/acs.jproteome.5c00540","journal-title":"J Proteome Res"},{"key":"2663_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010050","volume":"8","author":"NP Long","year":"2019","unstructured":"Long NP, Park S, Anh NH, Min JE, Yoon SJ, Kim HM, Nghi TD, Lim DK, Park JH, Lim J et al (2019) Efficacy of integrating a novel 16-gene biomarker panel and intelligence classifiers for differential diagnosis of rheumatoid arthritis and osteoarthritis. J Clin Med 8:50","journal-title":"J Clin Med"},{"key":"2663_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn M (2008) Building predictive models in R using the caret package. J Stat Softw 28:1\u201326","journal-title":"J Stat Softw"},{"key":"2663_CR25","doi-asserted-by":"publisher","unstructured":"Ribeiro MT, Singh S, Guestrin C (2016) \" Why should i trust you?\" Explaining the predictions of any classifierProceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining, pp. 1135\u20131144. https:\/\/doi.org\/10.1145\/2939672.293977","DOI":"10.1145\/2939672.293977"},{"key":"2663_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2025.08.003","author":"S Pande","year":"2025","unstructured":"Pande S, Varzideh F, Gambardella J, Jankauskas SS, Cerasuolo FA, Spinelli L, Kansakar U, De Luca A, Kurland IJ, Sidoli S et al (2025) Fabry disease cardiomyopathy: a state-of-the-art review. Prog Cardiovasc Dis. https:\/\/doi.org\/10.1016\/j.pcad.2025.08.003","journal-title":"Prog Cardiovasc Dis"},{"key":"2663_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-03895-x","volume":"20","author":"P Nandi","year":"2025","unstructured":"Nandi P, Ellis R, Hiros J, Howard P, Veleva-Rotse BO (2025) A composite measurement concept for monitoring cardiac function in Fabry disease. Orphanet J Rare Dis 20:382. https:\/\/doi.org\/10.1186\/s13023-025-03895-x","journal-title":"Orphanet J Rare Dis"},{"key":"2663_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100553","volume":"29","author":"H Rudolf","year":"2020","unstructured":"Rudolf H, M\u00fcgge A, Trampisch HJ, Scharnagl H, M\u00e4rz W, Kara K (2020) NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: the getABI-study. IJC Heart Vasc 29:100553","journal-title":"IJC Heart Vasc"},{"key":"2663_CR29","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.3390\/jcm13195953","volume":"13","author":"C Gatterer","year":"2024","unstructured":"Gatterer C, Beitzke D, Sunder-Plassmann G, Friedl M, Hohensinner P, Mann C, Ponleitner M, Graf S, Lenz M (2024) NT-proBNP reflects left ventricular hypertrophy rather than left ventricular dilatation or systolic dysfunction in patients with Fabry disease. J Clin Med 13:5953","journal-title":"J Clin Med"},{"key":"2663_CR30","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1093\/cvr\/cvae214","volume":"120","author":"M Takaoka","year":"2024","unstructured":"Takaoka M, Tadross JA, Al-Hadithi ABAK, Zhao X, Villena-Guti\u00e9rrez R, Tromp J, Absar S, Au M, Harrison J, Coll AP et al (2024) GDF15 antagonism limits severe heart failure and prevents cardiac cachexia. Cardiovasc Res 120:2249\u20132260. https:\/\/doi.org\/10.1093\/cvr\/cvae214","journal-title":"Cardiovasc Res"},{"key":"2663_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100046","volume":"9","author":"AM di Cana","year":"2021","unstructured":"di Cana AM, de Avila DX, Moreira GR, Villacorta H, Maisel AS (2021) Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases. Am Heart J Plus Cardiol Res Pract 9:100046. https:\/\/doi.org\/10.1016\/j.ahjo.2021.100046","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"2663_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000521329","volume":"47","author":"PC Greg\u00f3rio","year":"2022","unstructured":"Greg\u00f3rio PC, Biagini G, Cunha R, Budag J, Martins AM, Rivas LV, Schiefer EM, S\u00e1nchez-Ni\u00f1o MD, Ortiz A, Stinghen AEM et al (2022) Growth differentiation factor-15 and syndecan-1 are potential biomarkers of cardiac and renal involvement in classical Fabry disease under enzyme replacement therapy. Kidney Blood Press Res 47:229\u2013238. https:\/\/doi.org\/10.1159\/000521329","journal-title":"Kidney Blood Press Res"},{"key":"2663_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116024","volume":"25","author":"A Alonso-N\u00fa\u00f1ez","year":"2024","unstructured":"Alonso-N\u00fa\u00f1ez A, P\u00e9rez-M\u00e1rquez T, Alves-Villar M, Fern\u00e1ndez-Pereira C, Fern\u00e1ndez-Mart\u00edn J, Rivera-Gallego A, Melc\u00f3n-Crespo C, San Mill\u00e1n-Tejado B, Ruz-Zafra A, Garofano-L\u00f3pez R et al (2024) Inflammatory and cardiovascular biomarkers to monitor Fabry disease progression. Int J Mol Sci 25:6024","journal-title":"Int J Mol Sci"},{"key":"2663_CR34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","volume":"109","author":"S Kiechl","year":"2004","unstructured":"Kiechl S, Schett G, Wenning G, Redlich K, Oberhollenzer M, Mayr A, Santer P, Smolen J, Poewe W, Willeit J (2004) Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. Circulation 109:2175\u20132180","journal-title":"Circulation"},{"key":"2663_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/STROKEAHA.122.040800","volume":"54","author":"Z Zhu","year":"2023","unstructured":"Zhu Z, Guo D, Zhang K, Yang P, Jia Y, Shi M, Peng Y, Chen J, Wang A, Xu T et al (2023) Osteoprotegerin and ischemic stroke prognosis: a prospective multicenter study and Mendelian randomization analysis. Stroke 54:509\u2013517. https:\/\/doi.org\/10.1161\/STROKEAHA.122.040800","journal-title":"Stroke"},{"key":"2663_CR36","first-page":"1736","volume":"39","author":"E Thorin","year":"2023","unstructured":"Thorin E, Labb\u00e9 P, Lambert M, Mury P, Dagher O, Miquel G, Thorin-Trescases N (2023) Angiopoietin-like proteins: cardiovascular biology and therapeutic targeting for the prevention of cardiovascular diseases. Can J Cardiol 39:1736\u20131756","journal-title":"Can J Cardiol"},{"key":"2663_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2443.2010.01483.x","volume":"16","author":"N Comes","year":"2011","unstructured":"Comes N, Buie LK, Borr\u00e1s T (2011) Evidence for a role of angiopoietin-like 7 (ANGPTL7) in extracellular matrix formation of the human trabecular meshwork: implications for glaucoma. Genes Cells 16:243\u2013259","journal-title":"Genes Cells"},{"key":"2663_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113692","volume":"28","author":"X Chen","year":"2025","unstructured":"Chen X, Liu G, Zheng Z, Fu R, Song Y, Dou K (2025) Angiopoietin-like protein 7: a narrative review and its potential roles in post-myocardial infarction fibrosis. iScience 28:113692","journal-title":"iScience"},{"key":"2663_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01040-4","volume":"13","author":"XW Cheng","year":"2023","unstructured":"Cheng XW, Narisawa M, Wang H, Piao L (2023) Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications. Cell Biosci 13:91","journal-title":"Cell Biosci"},{"key":"2663_CR40","doi-asserted-by":"publisher","unstructured":"Xie X, Li Y, Xu S, Zhou P, Yang L, Xu Y, Qiu Y, Yang Y, Li Y (2022) Genetic blockade of NAAA cell-specifically regulates fatty acid ethanolamides (FAEs) metabolism and inflammatory responses. Frontiers in Pharmacology Volume 12 - 2021. https:\/\/doi.org\/10.3389\/fphar.2021.817603","DOI":"10.3389\/fphar.2021.817603"},{"key":"2663_CR41","doi-asserted-by":"publisher","DOI":"10.33963\/v.phj.106520","author":"A Szpakowicz","year":"2025","unstructured":"Szpakowicz A, Tuchli\u0144ski JK, Szum-Jakubowska A, Lisowska A, Dubat\u00f3wka M, Kondraciuk M, Roszkowska U, Stachurska Z, \u0141ukasiewicz A, Kami\u0144ski KA (2025) ST2, CLSTN2, IGFBP-7 and GDNF proteins gene expressions are associated with presence of carotid plaques in the general population independently from classical risk factors: a cross-sectional study. Polish Heart Journal (Kardiologia Polska). https:\/\/doi.org\/10.33963\/v.phj.106520","journal-title":"Polish Heart Journal (Kardiologia Polska)"},{"key":"2663_CR42","doi-asserted-by":"publisher","first-page":"15200","DOI":"10.3390\/ijms242015200","volume":"24","author":"R Roy","year":"2023","unstructured":"Roy R, Wilcox J, Webb AJ, O\u2019Gallagher K (2023) Dysfunctional and dysregulated nitric oxide synthases in cardiovascular disease: mechanisms and therapeutic potential. Int J Mol Sci 24:15200","journal-title":"Int J Mol Sci"},{"key":"2663_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mam.2004.09.003","volume":"26","author":"KM Naseem","year":"2005","unstructured":"Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26:33\u201365","journal-title":"Mol Aspects Med"},{"issue":"9","key":"2663_CR44","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1681\/ASN.2008111190","volume":"20","author":"L Shu","year":"2009","unstructured":"Shu L, Park JL, Byun J, Pennathur S, Kollmeyer J, Shayman JA (2009Sep 1) Decreased nitric oxide bioavailability in a mouse model of Fabry disease. Journal of the American society of Nephrology. 20(9):1975\u201385","journal-title":"Journal of the American society of Nephrology."},{"key":"2663_CR45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10545-017-0107-6","volume":"41","author":"X-L Meng","year":"2018","unstructured":"Meng X-L, Arning E, Wight-Carter M, Day TS, Jabbarzadeh-Tabrizi S, Chen S, Ziegler RJ, Bottiglieri T, Schneider JW, Cheng SH et al (2018) Priapism in a Fabry disease mouse model is associated with upregulated penile nNOS and eNOS expression. J Inherit Metab Dis 41:231\u2013238. https:\/\/doi.org\/10.1007\/s10545-017-0107-6","journal-title":"J Inherit Metab Dis"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02663-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:10:47Z","timestamp":1774782647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02663-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2663"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02663-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,29]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"56"}}